Loading…
Attending this event?
avatar for Benjamin Stevens

Benjamin Stevens

GlaxoSmithKline, United States
Director CMC Policy and Advocacy
Ben Stevens is a Director of CMC Policy and Advocacy at GlaxoSmithKline and has nearly 15 years of drug discovery and regulatory experience. Prior to GSK, Ben was a Director of Regulatory Affairs CMC at Alnylam, a Principal Consultant at PAREXEL and an acting Branch Chief in the Office of New Drug Products (ONDP) at the FDA. Before FDA, Ben spent seven years in pharmaceutical R&D at Pfizer and Merck. Ben received a Ph. D. in Chemistry from the University of Pittsburgh, a M.P.H. from the Johns Hopkins and is a co-author of over 20 publications and patents.

My Speakers Sessions

Monday, June 17
 

2:15pm PDT

#141: Innovation in Manufacturing Globally Room 11AB
 
Wednesday, June 19
 

10:00am PDT

#327: Enabling Innovation and Regulatory Agility to Address Sustainability, Environment, and Climate Goals Room 14AB
 
Share Modal

Share this link via

Or copy link